Impax Laboratories, LLC — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8e39bb95-5dfe-48ef-8fdc-1e15e0ea8dfd/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $775.8M | 2017-01-01 – 2017-12-31 | evidence 0001003642-18-000038 |
| FY 2016 | $824.4M | 2016-01-01 – 2016-12-31 | evidence 0001003642-17-000017 |
| FY 2015 | $860.5M | 2015-01-01 – 2015-12-31 | evidence 0001437749-16-025780 |
| FY 2014 | $596.0M | 2014-01-01 – 2014-12-31 | evidence 0001437749-15-003537 |
| FY 2013 | $511.5M | 2013-01-01 – 2013-12-31 | evidence 0001437749-14-002682 |
| FY 2012 | $581.7M | 2012-01-01 – 2012-12-31 | evidence 0001437749-13-001948 |
| FY 2011 | $512.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-085404 |
| FY 2010 | $879.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-085404 |
| FY 2009 | $358.4M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-085404 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Impax Laboratories, LLC — all facts · Net Income · Operating Income